1. Boren, J., et al. (2001). Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. Journal of Biological Chemistry, 276, 37747–37753.
2. Boren, J., et al. (2003). The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. Journal of Biological Chemistry, 278, 28395–28402. doi: 10.1074/jbc.M302932200 .
3. Boros, L. G., Torday, J. S., Lim, S., Bassilian, S., Cascante, M., & Lee, W. N. (2000). Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Research, 60, 1183–1185.
4. Boros, L. G., Bassilian, S., Lim, S., & Lee, W. N. (2001). Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas, 22, 1–7.
5. Boros, L. G., Cascante, M., & Lee, W. N. (2002a). Metabolic profiling of cell growth and death in cancer: Applications in drug discovery. Drug Discovery Today, 7, 364–372.